15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29

被引:42
作者
Cimen, Ismail [1 ]
Tuncay, Seda [1 ]
Banerjee, Sreeparna [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey
关键词
COLON-CANCER CELLS; ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTIONAL REPRESSION; TUMOR-METASTASIS; PROSTATE-CANCER; PPAR-GAMMA; ACID; GENE; OVEREXPRESSION; APOPTOSIS;
D O I
10.1111/j.1349-7006.2009.01313.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal carcinoma (CRC) is often lethal when invasion and/or metastasis occur. 15-Lipoxygenase-1 (15-LO-1), a member of the inflammatory eicosanoid pathway, oxidatively metabolizes linoleic acid and its expression is repressed in CRC. In this study, we investigated the hypothesis that the lack of 15-LO-1 expression in CRC cells might contribute to tumorigenesis. Therefore we introduced 15-LO-1 into HCT-116 and HT-29 cells that do not have detectable levels of 15-LO-1. Our data indicate that expression of 15-LO-1 significantly decreased cell proliferation and increased apoptosis. In addition, we observed a reduction in adhesion to fibronectin, anchorage-independent growth on soft agar, cellular motility and ability to heal a scratch wound, and migratory and invasive capacity across Matrigel. 15-LO-1 expression also reduced the expression of metastasis associated protein-1, a part of the nucleosome remodeling and histone deacetylase silencing complex. We propose that 15-LO-1 expression in CRC might contribute to the inhibition of metastatic capacity in vitro and can be exploited for therapeutic purposes. (Cancer Sci 2009;100: 2283-2291).
引用
收藏
页码:2283 / 2291
页数:9
相关论文
共 44 条
[1]  
Cuendet M, 2000, Drug Metabol Drug Interact, V17, P109
[2]   IAPs - More than just inhibitors of apoptosis proteins [J].
Dubrez-Daloz, Laurence ;
Dupoux, Alban ;
Cartier, Jessy .
CELL CYCLE, 2008, 7 (08) :1036-1046
[3]   What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? [J].
Fuerstenberger, G. ;
Krieg, P. ;
Mueller-Decker, K. ;
Habenicht, A. J. R. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) :2247-2254
[4]  
Giannini R, 2005, ANTICANCER RES, V25, P4287
[5]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[6]   15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth [J].
Hennig, Rene ;
Kehl, Timo ;
Noor, Seema ;
Ding, Xian-Zhong ;
Rao, Sambasiva M. ;
Bergmann, Frank ;
Furstenberger, Gerhard ;
Buchler, Markus W. ;
Friess, Helmut ;
Krieg, Peter ;
Adrian, Thomas E. .
NEOPLASIA, 2007, 9 (11) :917-926
[7]   The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells [J].
Hsi, LC ;
Xi, XP ;
Lotan, R ;
Shureiqi, I ;
Lippman, SM .
CANCER RESEARCH, 2004, 64 (23) :8778-8781
[8]   Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate -: Alteration in peroxisome proliferator-activated receptor γ [J].
Hsi, LC ;
Wilson, LC ;
Eling, TE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40549-40556
[9]   15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor γ via the MAPK signaling pathway [J].
Hsi, LC ;
Wilson, L ;
Nixon, J ;
Eling, TE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34545-34552
[10]  
Ikawa H, 1999, CANCER RES, V59, P360